Frequently asked questions (FAQs) Is compounded semaglutide safe
Soule S, King JA, Millar RP
A comprehensive meta-analysis collecting all available data from randomized trials on the effects of glucagon-like peptide 1 receptor agonists on the risk of different malignancies
The LEADER and SUSTAIN-6 trials demonstrated that semaglutide reduces the risk of major adverse cardiac events, including heart attack and stroke, particularly in patients with existing type 2 diabetes or cardiovascular disease
While Eli Lilly saw the results as indicators of success, investors on the call expressed concerns
Whereas protein hydrolysate and peptones have been found to stimulate L cell secretion in several studies [18, 19, 20], amino acid mixtures are a less reliable stimulus [11, 12, 20]